awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q35993027-7756FBD6-943A-4557-9CE5-8180D73C9C63
Q35993027-7756FBD6-943A-4557-9CE5-8180D73C9C63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35993027-7756FBD6-943A-4557-9CE5-8180D73C9C63
Efficacy and safety of rituximab in moderately-to-severely active systemic lupus erythematosus: the randomized, double-blind, phase II/III systemic lupus erythematosus evaluation of rituximab trial.
P2860
Q35993027-7756FBD6-943A-4557-9CE5-8180D73C9C63
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35993027-7756FBD6-943A-4557-9CE5-8180D73C9C63
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
43fbdeffa8b10ee494de954e8256264e92009367
P2860
Efficacy of rituximab (anti-CD20) for refractory systemic lupus erythematosus involving the central nervous system.